Belize population-based survey confirms the high prevalence of Chronic Kidney Disease and its risk factors in Central America.
作者信息
Ordunez Pedro, Martinez Ramon
机构信息
Department of Non-Communicable Diseases and Mental Health. Pan American Health Organization. Washington, DC. U.S.A.
出版信息
Lancet Reg Health Am. 2021 Sep;1:None. doi: 10.1016/j.lana.2021.100035.
Abstract
摘要
相似文献
1
Belize population-based survey confirms the high prevalence of Chronic Kidney Disease and its risk factors in Central America.
Lancet Reg Health Am. 2021 Sep;1:None. doi: 10.1016/j.lana.2021.100035.
2
Prevalence and Risk Factors for Chronic Kidney Disease in Belize: A Population-based Survey.
Lancet Reg Health Am. 2021 Jul 17;1:100013. doi: 10.1016/j.lana.2021.100013. eCollection 2021 Sep.
3
The recent migrations of Belize, Central America.
Int Migr Rev. 1984 Summer;18(2):319-25.
4
Distribution of Triatoma dimidiata sensu lato (Reduviidae: Triatominae) and Risk Factors Associated with Household Invasion in Northern Belize, Central America.
J Med Entomol. 2022 Mar 16;59(2):764-771. doi: 10.1093/jme/tjab227.
5
First record and demonstration of a southward expansion of Aedes albopictus into Orange Walk Town, Belize, Central America.
J Am Mosq Control Assoc. 2013 Dec;29(4):380-2. doi: 10.2987/13-6364.1.
6
Ticks and rickettsiae from wildlife in Belize, Central America.
Parasit Vectors. 2016 Feb 2;9:62. doi: 10.1186/s13071-016-1348-1.
7
The prevalence of hepatitis A, B and C infection among different ethnic groups in Belize.
Am J Trop Med Hyg. 1993 Oct;49(4):430-4. doi: 10.4269/ajtmh.1993.49.430.
8
Prevalence of antibody to Trypanosoma cruzi in three populations in Belize.
Am J Trop Med Hyg. 1997 Sep;57(3):298-301. doi: 10.4269/ajtmh.1997.57.298.
9
Growth status of school-age Mayan children in Belize, Central America.
Am J Phys Anthropol. 1994 Feb;93(2):217-27. doi: 10.1002/ajpa.1330930206.
10
Histoplasmosis in Belize, Central America.
Am J Trop Med Hyg. 1978 May;27(3):558-61. doi: 10.4269/ajtmh.1978.27.558.
引用本文的文献
1
MAFLD: Exploring the Systemic Effects Beyond Liver.
J Community Hosp Intern Med Perspect. 2025 Jan 6;15(1):42-48. doi: 10.55729/2000-9666.1426. eCollection 2025.
2
Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations.
World J Gastroenterol. 2022 Oct 21;28(39):5691-5706. doi: 10.3748/wjg.v28.i39.5691.
本文引用的文献
1
Prevalence and Risk Factors for Chronic Kidney Disease in Belize: A Population-based Survey.
Lancet Reg Health Am. 2021 Jul 17;1:100013. doi: 10.1016/j.lana.2021.100013. eCollection 2021 Sep.
2
Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study.
Lancet Glob Health. 2020 Apr;8(4):e511-e523. doi: 10.1016/S2214-109X(20)30035-8.
3
Burden of disease: Closing the gaps in the burden of end-stage kidney disease in Latin America.
Clin Nephrol. 2020 Supplement-Jan;93(1):55-59. doi: 10.5414/CNP92S109.
4
Chronic kidney diseases in agricultural communities: report from a workshop.
Kidney Int. 2019 Nov;96(5):1071-1076. doi: 10.1016/j.kint.2019.06.024. Epub 2019 Aug 2.
5
The Chronic Kidney Disease Epidemic in El Salvador: A Cross-Sectional Study.
MEDICC Rev. 2019 Apr-Jul;21(2-3):29-37. doi: 10.37757/MR2019.V21.N2-3.7.
6
Chronic kidney disease mortality trends in selected Central America countries, 1997-2013: clues to an epidemic of chronic interstitial nephritis of agricultural communities.
J Epidemiol Community Health. 2018 Apr;72(4):280-286. doi: 10.1136/jech-2017-210023. Epub 2018 Feb 2.
7
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy.
Lancet. 2017 Oct 21;390(10105):1888-1917. doi: 10.1016/S0140-6736(17)30788-2. Epub 2017 Apr 20.
8
Chronic interstitial nephritis in agricultural communities: a worldwide epidemic with social, occupational and environmental determinants.
Nephrol Dial Transplant. 2017 Feb 1;32(2):234-241. doi: 10.1093/ndt/gfw346.
Zotero 插件